NPI: 1124026273 · SANTA MONICA, CA 90404 · General Acute Care Hospital · NPI assigned 07/12/2005
Authorized official ANDERSON, DONALD controls 20+ related entities in our dataset. Read more
| Authorized Official | ANDERSON, DONALD (ASSISTANT SECRETARY ENROLLMENTS) |
| NPI Enumeration Date | 07/12/2005 |
Other providers sharing the same authorized official: ANDERSON, DONALD
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 37,351 | $700K |
| 2019 | 36,661 | $693K |
| 2020 | 28,236 | $563K |
| 2021 | 32,304 | $692K |
| 2022 | 31,714 | $898K |
| 2023 | 44,480 | $1.03M |
| 2024 | 43,260 | $939K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 0450 | Emergency room services | 28,552 | 24,821 | $1.16M |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | 1,974 | 1,919 | $427K |
| 70450 | Computed tomography, head or brain; without contrast material | 3,929 | 3,754 | $344K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 2,026 | 1,963 | $322K |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 2,031 | 1,916 | $304K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 6,509 | 6,088 | $260K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 9,762 | 9,019 | $189K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 2,575 | 2,241 | $134K |
| 80053 | Comprehensive metabolic panel | 16,075 | 14,560 | $124K |
| 99284 | Emergency department visit for the evaluation and management, high severity | 1,708 | 1,581 | $122K |
| 96375 | Therapeutic injection; each additional sequential IV push | 4,685 | 4,211 | $119K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 2,002 | 1,939 | $102K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 18,506 | 16,348 | $91K |
| 96361 | Intravenous infusion, hydration; each additional hour | 4,293 | 3,988 | $86K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 1,434 | 1,291 | $79K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 958 | 937 | $78K |
| 71045 | Radiologic examination, chest; single view | 7,197 | 6,856 | $78K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1,912 | 1,780 | $69K |
| 99199 | Unlisted special service, procedure or report | 1,709 | 1,494 | $68K |
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 1,551 | 1,402 | $67K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 3,606 | 3,214 | $67K |
| 93970 | 1,243 | 1,091 | $65K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 1,587 | 1,532 | $62K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 1,113 | 995 | $57K |
| Z7502 | 1,600 | 1,529 | $55K | |
| 71275 | Computed tomographic angiography, chest, with contrast material | 332 | 328 | $50K |
| 84484 | 7,339 | 5,485 | $49K | |
| 80306 | 3,764 | 3,473 | $47K | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 1,561 | 1,408 | $45K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 839 | 770 | $43K |
| 83880 | 2,091 | 1,975 | $41K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 3,711 | 3,334 | $36K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 3,233 | 3,126 | $32K |
| 72125 | Computed tomography, cervical spine; without contrast material | 294 | 284 | $30K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 317 | 313 | $27K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 2,629 | 791 | $27K |
| J7030 | Infusion, normal saline solution , 1000 cc | 4,064 | 3,617 | $26K |
| 83690 | 5,293 | 4,951 | $25K | |
| 82330 | 1,988 | 1,873 | $23K | |
| 82077 | 1,963 | 1,810 | $22K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 4,183 | 3,872 | $22K |
| J3490 | Unclassified drugs | 3,705 | 2,925 | $21K |
| 81001 | 9,832 | 9,182 | $21K | |
| 84443 | Thyroid stimulating hormone (TSH) | 2,450 | 2,379 | $17K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 331 | 324 | $16K |
| 81025 | 3,775 | 3,580 | $16K | |
| 93971 | 257 | 212 | $16K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 1,244 | 1,162 | $14K |
| 71046 | Radiologic examination, chest; 2 views | 910 | 871 | $13K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 1,078 | 950 | $13K |
| 87040 | 1,949 | 1,020 | $13K | |
| J2270 | Injection, morphine sulfate, up to 10 mg | 1,972 | 1,654 | $12K |
| 80048 | Basic metabolic panel (calcium, ionized) | 2,489 | 2,252 | $12K |
| 84145 | 978 | 953 | $12K | |
| 83605 | 1,768 | 1,504 | $12K | |
| 85610 | 3,923 | 3,726 | $12K | |
| 80179 | 846 | 800 | $10K | |
| 80143 | 857 | 812 | $10K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 80 | 79 | $10K |
| 80047 | 1,661 | 1,603 | $10K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 2,259 | 2,131 | $10K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 1,995 | 698 | $9K |
| 85730 | 2,291 | 2,198 | $9K | |
| 83735 | 2,152 | 1,971 | $8K | |
| 0250 | 8,686 | 4,973 | $8K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 144 | 139 | $7K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 300 | 293 | $7K |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 332 | 325 | $7K |
| 0762 | 132 | 65 | $7K | |
| 73562 | 288 | 263 | $6K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 640 | 633 | $6K |
| J2060 | Injection, lorazepam, 2 mg | 1,196 | 1,055 | $6K |
| 0301 | 100 | 88 | $5K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 310 | 294 | $5K |
| 85379 | 676 | 666 | $5K | |
| 87631 | 155 | 152 | $5K | |
| 73630 | 199 | 187 | $4K | |
| 80061 | Lipid panel | 1,208 | 1,194 | $4K |
| 85027 | 1,203 | 1,113 | $3K | |
| 83036 | Hemoglobin; glycosylated (A1C) | 1,085 | 1,071 | $3K |
| 0270 | 1,773 | 1,139 | $3K | |
| 84439 | 988 | 955 | $3K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 332 | 282 | $3K |
| 87186 | 607 | 587 | $3K | |
| 80076 | 493 | 481 | $2K | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 74 | 69 | $2K |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 187 | 170 | $2K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 43 | 39 | $2K |
| 73610 | 107 | 105 | $2K | |
| 90715 | 70 | 68 | $2K | |
| 70496 | 13 | 13 | $2K | |
| 87077 | 454 | 448 | $2K | |
| Z7610 | 120 | 103 | $2K | |
| 73030 | 104 | 96 | $2K | |
| 82607 | 416 | 410 | $1K | |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 17 | 14 | $1K |
| 71250 | 24 | 24 | $1K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 84 | 84 | $1K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 84 | 84 | $1K |
| 73130 | 57 | 53 | $1K | |
| 87400 | 320 | 307 | $1K | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 273 | 255 | $1K |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 244 | 237 | $1K |
| 0510 | 188 | 168 | $1K | |
| 36415 | Collection of venous blood by venipuncture | 1,617 | 1,463 | $1K |
| 82728 | 303 | 300 | $1K | |
| 96376 | 222 | 187 | $895.58 | |
| 85652 | 888 | 844 | $809.05 | |
| 87430 | 131 | 129 | $739.48 | |
| 86140 | 404 | 384 | $691.01 | |
| 85380 | 232 | 219 | $672.12 | |
| J7050 | Infusion, normal saline solution, 250 cc | 141 | 115 | $654.94 |
| 0324 | 41 | 38 | $638.72 | |
| 87081 | 171 | 165 | $617.83 | |
| 70551 | Magnetic resonance imaging, brain; without contrast material | 13 | 12 | $612.25 |
| 82550 | 119 | 103 | $573.26 | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 128 | 126 | $543.74 |
| 86900 | 254 | 236 | $517.81 | |
| 83540 | 351 | 348 | $501.31 | |
| 83550 | 332 | 330 | $484.71 | |
| 99221 | 18 | 12 | $477.40 | |
| 86901 | 238 | 222 | $471.84 | |
| 84702 | 45 | 41 | $414.18 | |
| 84100 | 231 | 204 | $354.77 | |
| 96367 | 12 | 12 | $331.39 | |
| 84550 | 268 | 261 | $263.29 | |
| J1630 | Injection, haloperidol, up to 5 mg | 45 | 40 | $223.83 |
| 87205 | 107 | 96 | $211.64 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 71 | 69 | $198.81 |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | 1,675 | 1,530 | $189.41 |
| J1170 | Injection, hydromorphone, up to 4 mg | 19 | 16 | $185.28 |
| 0636 | 642 | 375 | $184.29 | |
| 86850 | 58 | 54 | $168.92 | |
| A4217 | Sterile water/saline, 500 ml | 30 | 26 | $152.46 |
| 84481 | 12 | 12 | $134.46 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | 14 | 12 | $90.48 |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 16 | 15 | $81.05 |
| A4649 | Surgical supply; miscellaneous | 312 | 256 | $65.30 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 12 | 12 | $61.04 |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 25 | 14 | $52.23 |
| 87070 | 14 | 13 | $48.55 | |
| J2470 | Injection, pantoprazole sodium, 40 mg | 12 | 12 | $39.29 |
| 87147 | 14 | 14 | $25.44 | |
| 82570 | 13 | 13 | $5.18 | |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | 12 | 12 | $0.00 |
| 0258 | 24 | 22 | $0.00 | |
| A9270 | Non-covered item or service | 39 | 15 | $0.00 |
| S9445 | Patient education, not otherwise classified, non-physician provider, individual, per session | 15 | 13 | $0.00 |